SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013104
Filing Date
2022-05-12
Accepted
2022-05-12 17:28:21
Documents
66
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 636900
2 ex10-1.htm EX-10.1 45898
3 ex10-2.htm EX-10.2 47005
4 ex31-1.htm EX-31.1 21577
5 ex31-2.htm EX-31.2 18386
6 ex32-1.htm EX-32.1 8414
7 ex32-2.htm EX-32.2 8387
  Complete submission text file 0001493152-22-013104.txt   3722752

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cing-20220331.xsd EX-101.SCH 31785
9 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cing-20220331_cal.xml EX-101.CAL 51077
10 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cing-20220331_def.xml EX-101.DEF 135153
11 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cing-20220331_lab.xml EX-101.LAB 271376
12 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cing-20220331_pre.xml EX-101.PRE 210424
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 443565
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40874 | Film No.: 22919184
SIC: 2834 Pharmaceutical Preparations